AVE 50.0% 0.3¢ avecho biotechnology limited

insulin focus reemerging?

  1. 5,852 Posts.
    lightbulb Created with Sketch. 340
    Just looking at the POH website "Insulin" has its own tab and I am wondering whether they are perhaps about to raise its profile again.

    I cannot remember what the original insulin page said but it looks like they may have tweaked it a little.

    "Phosphagenics is now reviewing commercial opportunities for this project."

    I haven't looked at the website for ages.

    Can anyone remember if that statement was there previously?

    Is it a stale statement or something they are confident enough about to put out publicly, albeit very softly.

    If it is a stale statement it should really be removed as the trials were 2009 and well nothing seems to have occured. Pets with Novartis perhaps, but that looks dormant.

    I wonder having nailed opiod patches that this has led to a strong belief in smaller patches being a very effenient insulin delivery alternative?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(50.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $52 21.66K

Buyers (Bids)

No. Vol. Price($)
11 6846739 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 41919123 29
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.